Pfizer Ventures (US) LLC 4
4 · BioAtla, Inc. · Filed Dec 22, 2020
Insider Transaction Report
Form 4
BioAtla, Inc.BCAB
PFIZER INC
10% Owner
Transactions
- Conversion
Common Stock
2020-12-18+2,238,090→ 2,238,090 total(indirect: See Footnote(2)) - Conversion
Series D Convertible Preferred Stock
2020-12-18−2,238,090→ 0 total(indirect: See Footnote (2))→ Common Stock (2,238,090 underlying)
Footnotes (2)
- [F1]Each share of Series D Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering, for no additional consideration. The Series D Convertible Preferred Stock had no expiration date.
- [F2]Such shares are held of record by Pfizer Ventures (US) LLC, a wholly-owned subsidiary of Pfizer Inc.